the company, CRP programs and facilities are overseen by attending staff veterinarians and AALAS-certified technicians. Safety Assessment Labcorp Drug Development says it offers General Toxicology Studies, Genetic Toxicology, Immunotoxicology, Nonclinical Pathology Services, Safety Pharmacology, Services, Developmental and Reproductive Toxicology, (DART) Studies, and SEND - Standard for the Exchange of Nonclinical Data. Consulting & Partnering Labcorp Drug Development partners with pharmaceutical companies and biotechnology companies in various consulting and partnership agreements by offering drug development program management services, alliance management, early phase development solutions, Labcorp Drug Development MarketPlace, drug development consulting, access and strategy, and evidence generation. Clinical Development Labcorp Drug Development supports companies with their clinical trials, which involves early clinical / Phase IIa, Phase IIb / III services, clinical data management analysis and reporting, regulatory services, and Phase IV solutions. Clinical Testing In the clinical testing space, Labcorp Drug Development says it offers services involving flow cytometry, a central laboratory, biomarker testing capabilities, companion diagnostics, genomics, vaccines, and immunotherapeutics. Commercialization In the drug development commercialization space, Labcorp Drug Development reports to offer a service called MarketPlace and also offers patient support, field services, drug safety and pharmacovigilance. Manufacturing Support On the manufacturing side, Labcorp Drug Development reports that it offers chemistry, manufacturing and control (CMC) services. Informatics In 2011, Labcorp Drug Development (then Covance) launched its Xcellerate platform as an informatics tool to help optimize clinical trial performance. In 2018, Xcellerate won industry recognition with the Scrip Award for Best Technological Development in Clinical Trials. In 2016, Labcorp Drug Development entered a five-year strategic alliance with Global Specimen Solutions and the use of their specimen management product, GlobalCODE, among other software products. In 2017, Global Specimen Solutions, Inc. was listed as a Labcorp subsidiary. Functional Service Provision (FSP) Labcorp Drug Development reports to help with staffing biopharmaceutical companies in the roles of clinical operations and clinical analytics under the Functional Service Provider (FSP) model. The acquisition of Chiltern in 2017 (as Covance) helped Labcorp Drug Development grow its FSP capabilities. Animal health and welfare Labcorp Drug Development states its purpose for animal research helps support fundamental studies, toxicological and safety evaluation, production and quality control, efficacy testing and diagnosis in the drug development process. Labcorp Drug Development reports that it has an excellent record of complying with animal welfare regulations, including the European Council Directive 2010–63/EU, the U.S. Animal Welfare Act and the requirements set forth by the United